Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PBMIX vs. CSMD: which is better?

Bottom line

PBMIX vs CSMD: the short answer

PBMIX (Polen U.S. SMID Company Growth Fund) and CSMD (Congress SMid Growth ETF) are both mutual funds.

CSMD is cheaper at 0.68% vs 1.05% — a difference of $37 a year per $10,000 invested.

Over one year, CSMD returned +5.7% vs +1.5% for PBMIX (reporting dates differ).

Updated Nov 19, 2026

PBMIX vs CSMD side by side

PBMIXCSMD
TypeMutual fundETF
Fund familyFundvantageTortoise
CategorySmall-CapSmall-Cap
Expense ratio1.05%0.68%
Annual cost per $10k$105$68
10-yr cost on $10k (prospectus)$2,343$847
Max front load—None
12b-1 fee—0%
1-yr return+1.5%+5.7%
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter+14.7%+12.5%
Worst quarter−29.5%−7.3%
Net assets (fund)—$454.1M
Number of holdings—47
Portfolio turnover58%23%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPBMIXCSMDDifference
2024+1.5%+12.1%−10.6%

Source: Fund prospectus bar charts

Holdings overlap

PBMIX and CSMD share none of their top holdings.

PBMIX top 10

    CSMD top 10

    1. Curtiss-Wright Corp — 4.23%
    2. nVent Electric PLC — 3.62%
    3. Carpenter Technology Corp — 3.49%
    4. Valmont Industries Inc — 3.47%
    5. Rubrik Inc — 3.35%
    6. Halozyme Therapeutics Inc — 2.87%
    7. BJ's Wholesale Club Holdings I — 2.80%
    8. Repligen Corp — 2.78%
    9. Medpace Holdings Inc — 2.78%
    10. Rambus Inc — 2.72%

    FAQ

    What is the difference between PBMIX and CSMD?
    PBMIX (Polen U.S. SMID Company Growth Fund) and CSMD (Congress SMid Growth ETF) are both mutual funds. CSMD is cheaper at 0.68% vs 1.05% — a difference of $37 a year per $10,000 invested.
    Which is cheaper, PBMIX or CSMD?
    CSMD has the lower expense ratio (0.68%).
    Should I own both PBMIX and CSMD?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.